Why the study?
Plaque morphology and composition play an important role in risk stratification of carotid atherosclerotic lesions, making the assessment of vulnerable carotid plaques with contrast-enhanced ultrasound clinically valuable.
Does contrast-enhanced ultrasound (CEUS) accurately detect vulnerable carotid plaques and predict future cerebrovascular events in patients with carotid atherosclerotic disease?
Does contrast-enhanced ultrasound (CEUS) accurately detect vulnerable carotid plaques and predict future cerebrovascular events in patients with carotid atherosclerotic disease?
Carotid contrast-enhanced ultrasound (CEUS) is a promising imaging modality for characterizing vulnerable carotid plaques and predicting future cardiovascular events, though large prospective studies are still needed.
CEUS may refine carotid plaque risk stratification in practice; leaves open prospective validation against clinical events.
Not only the degree of luminal narrowing but also the plaque morphology and composition play an important role in risk stratification of carotid atherosclerotic lesions. During the last few years, carotid contrast-enhanced ultrasound (CEUS) has emerged as a valuable imaging tool to assess such vulnerable carotid plaques. This review article discussed the use of CEUS for the detection of carotid plaque irregularities and ulcerations as well as the quantification of intraplaque neovascularization and its correlation with histology and inflammatory biomarkers. Apart from evaluating for markers of vulnerable carotid plaques, CEUS enhancement is directly associated with past cerebrovascular events. More importantly, preliminary evidence has shown that CEUS could be used to predict future cerebrovascular and cardiovascular events. Despite the progress in CEUS imaging for carotid atherosclerotic disease, past studies still suffer from the retrospective nature, small sample size, and a lack of matched, well controlled prospective studies. In the future, large multi-center prospective studies addressing the relationship between CEUS findings and patient clinical outcomes in carotid atherosclerotic disease are warranted.
No takes yet. Share an insight, caveat, or question.
Rafailidis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: